NEW YORK, Nov. 13 – Third Wave Technologies has licensed over 3,300 genetic markers from Japan’s Institute of Physical and Chemical Research, the organizations announced Tuesday.

The agreement gives Third Wave Technologies, based in Madison, Wis., the worldwide license, excluding Japan, to research and clinical diagnostic applications to patents for genetic markers within approximately 200 genes related to drug metabolism regulation, according to the company.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

With H3Africa, Charles Rotimi has been working to bolster the representation of African participants and African researchers in genomics, Newsweek reports.

NPR reports that government and private insurers are being slow to cover recently approved CAR-T cell therapies.

CNBC reports that there are thousands of genetic tests available for consumers to chose between.

In Nature this week: genomic analysis of ducks, whole-genome doubling among tumor samples, and more.